[Molecular mimicry between human thyroid peroxidase, thyroglobulin, cosinophil peroxidase, IL-24 and microorganisms

Andrés Sánchez1,2, Valentina García1, Yuliana Marcela Emiliani-Navarro1

  • 1Faculty of Health, Medical Research Group (GINUMED), Rafael Nuñez University Corporation, Cartagena, Colombia.

Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
|April 29, 2024
PubMed
Abstract

Insights

Molecular mimicry between thyroid peroxidase (TPO), eosinophil peroxidase (EPX), and microbial antigens suggests infections may trigger autoimmune conditions like urticaria and hypothyroidism. Further in vitro studies are needed.

Area of Science:

  • Immunology
  • Molecular Biology
  • Bioinformatics

Context:

  • Autoimmune diseases like urticaria and hypothyroidism are sometimes linked to infections.
  • The underlying mechanisms for this association remain unclear.
  • Molecular mimicry is a proposed mechanism where microbial antigens resemble self-antigens, potentially triggering autoimmune responses.

Purpose:

  • To identify molecular mimicry between human proteins (thyroid peroxidase [TPO], eosinophil peroxidase [EPX], thyroglobulin, IL24) and microbial antigens.
  • To investigate potential cross-reactive epitopes shared between human proteins and antigens from parasites and bacteria.

Summary:

  • In silico analysis revealed molecular mimicry between TPO/EPX and antigens from bacteria (e.g., Campylobacter jejuni) and nematodes (e.g., Anisakis simplex, Toxocara canis, Trichinella pseudospiralis).
  • Specifically, 38 microbial antigens showed 30-45% identity with human proteins, with significant alignments found between Anisakis simplex proteins and EPX.
  • 220 epitopes were predicted, with 10 shared epitopes identified between peroxidasin-like proteins and TPO/EPX, suggesting potential cross-reactivity.

Impact:

  • These findings suggest molecular mimicry could be a key mechanism linking infections to urticaria and hypothyroidism.
  • The study highlights specific microbial antigens and epitopes involved in potential cross-reactivity.
  • Further in vitro validation is required to confirm these in silico predictions and elucidate the role of molecular mimicry in these autoimmune conditions.